Screener
Revolution Medicines, Inc. RVMD Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335104
FAQ
- What is Revolution Medicines, Inc.'s other non-current liabilities?
- Revolution Medicines, Inc. (RVMD) reported other non-current liabilities of $1.65M in Q2 2026.
- How has Revolution Medicines, Inc.'s other non-current liabilities changed year-over-year?
- Revolution Medicines, Inc.'s other non-current liabilities decreased by 77.1% year-over-year, from $7.2M to $1.65M.
- What is the long-term trend for Revolution Medicines, Inc.'s other non-current liabilities?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s other non-current liabilities has grown at a 13.8% compound annual growth rate (CAGR), from $632K to $1.21M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Revolution Medicines, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude